NasdaqCM - Delayed Quote USD

Ekso Bionics Holdings, Inc. (EKSO)

1.2500 -0.0300 (-2.34%)
At close: April 26 at 4:00 PM EDT
1.2900 +0.04 (+3.20%)
After hours: April 26 at 5:25 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Scott G. Davis CEO & Director 535.8k -- 1971
Mr. Jerome Wong Corporate Controller, Corporate Secretary & CFO 356.81k -- 1975
Mr. Jason C. Jones Chief Operating Officer 378.1k -- --
Ms. Rachael Anderson Global Director of Marketing & Strategic Growth -- -- --
Mr. Anthony Pratt Vice President of Sales -- -- --
Ms. Ann Cookson Human Resources Director -- -- --
Ms. Foon Lim Chwee President of APAC -- -- --
Mr. Stephan Aderhold Senior VP & GM of EMEA -- -- --

Ekso Bionics Holdings, Inc.

101 Glacier Point
Suite A
San Rafael, CA 94901
United States
510 984 1761 https://www.eksobionics.com
Sector: 
Healthcare
Full Time Employees: 
70

Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Corporate Governance

Ekso Bionics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Apr 29, 2024
Ekso Bionics Holdings, Inc. Earnings Call

Related Tickers

STXS Stereotaxis, Inc.
2.3000
-2.13%
 
HBIO Harvard Bioscience, Inc.
3.6200
+1.69%
 
UTMD Utah Medical Products, Inc.
65.92
-0.56%
 
ATR AptarGroup, Inc.
143.33
+2.25%
 
OCPNF Olympus Corporation
13.95
-1.13%
 
TRUMY Terumo Corporation
16.60
-0.12%
 
AVGR Avinger, Inc.
3.7301
-3.11%
 
SSMXY Sysmex Corporation
15.89
+0.25%
 
MBOT Microbot Medical Inc.
0.8800
+0.32%
 
NEPH Nephros, Inc.
2.1900
+2.34%